Integral Health Asset Management’s CATALENT, INC. CTLT Stock Holding History

Integral Health Asset Management’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-160,000	Closed	-$7.28M	–	97
2023 Q3	$7.28M	Buy	+160,000	New	+$7.48M	1.01%	40
2023 Q2	–	Sell	-50,000	Closed	-$3.29M	–	101
2023 Q1	$3.29M	Buy	+50,000	New	+$3.09M	0.66%	53
2020 Q4	–	Sell	-35,000	Closed	-$3M	–	86
2020 Q3	$3M	Sell	35,000 -65,000	-65%	-$5.5M	0.92%	40
2020 Q2	$7.33M	Sell	100,000 -50,000	-33%	-$3.39M	2.2%	19
2020 Q1	$7.79M	Buy	+150,000	New	+$8.19M	3.43%	8

Other funds holding CTLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Integral Health Asset Management's CTLT Position: Q4 2023 in Review

Integral Health Asset Management sold out of CATALENT, INC. (CTLT) in Q4 2023, closing a stake of 160,000 shares — an estimated $7.28M sold.

Integral Health Asset Management first reported a position in CTLT in Q1 2020 and held it in 5 quarters. The position peaked at $7.79M in Q1 2020. 424 funds tracked by Wall St. Rank hold CTLT as of Q4 2023.

Integral Health Asset Management reported no remaining CATALENT, INC. position as of Q4 2023 after selling out during the quarter.
Integral Health Asset Management sold 160,000 CATALENT, INC. shares in Q4 2023, an estimated $7.28M.
Integral Health Asset Management first reported a position in CATALENT, INC. in Q1 2020 and held it in 5 quarters.
Integral Health Asset Management's CATALENT, INC. position peaked at $7.79M in Q1 2020.
424 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2023.

Based on Integral Health Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.